Axsome Therapeutics, Inc.

This study looked at the long-term safety and effectiveness of an experimental drug called AXS-05 for people with treatment-resistant depression (depression that hasn't improved with other treatments). The study enrolled 181 adults who either completed a prior AXS-05 study or cur…

This study tested the long-term safety of AXS-05, an experimental drug for agitation in people with Alzheimer's disease. It included 139 adults who had already completed earlier studies. The trial was terminated early, and its main goal was to track side effects, not to cure Alzh…